| Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao, RL Francis, ... Nature 599 (7885), 465-470, 2021 | 132 | 2021 |
| The miR-183/96/182 cluster regulates macrophage functions in response to Pseudomonas aeruginosa CK Muraleedharan, SA McClellan, SA Ekanayaka, R Francis, A Zmejkoski, ... Journal of Innate Immunity 11 (4), 347-358, 2019 | 30 | 2019 |
| One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody–Drug Conjugates through Site-Specific Chemoenzymatic … C Ou, C Li, R Zhang, Q Yang, G Zong, Y Dai, RL Francis, S Bournazos, ... Bioconjugate Chemistry 32 (8), 1888-1897, 2021 | 23 | 2021 |
| Glycolytic inhibitor 2-deoxyglucose suppresses inflammatory response in innate immune cells and experimental staphylococcal endophthalmitis R Francis, PK Singh, S Singh, S Giri, A Kumar Experimental eye research 197, 108079, 2020 | 23 | 2020 |
| Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies LD Hazlett, SA Ekanayaka, SA McClellan, R Francis Investigative Ophthalmology & Visual Science 60 (8), 2978-2989, 2019 | 23 | 2019 |
| HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice SA Ekanayaka, SA McClellan, X Peng, RP Barrett, R Francis, LD Hazlett Journal of Ocular Pharmacology and Therapeutics 34 (10), 659-669, 2018 | 16 | 2018 |
| Fc-engineered antibody therapeutics with improved efficacy against COVID-19 R Yamin, AT Jones, HH Hoffmann, KS Kao, RL Francis, TP Sheahan, ... Research square, 2021 | 9 | 2021 |
